Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.5K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.5K
Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

3.0K
A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
3.0K
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

2.2K
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
2.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

522
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
522
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

71
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
71
Modeling in Therapy01:26

Modeling in Therapy

683
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
683

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Financing Medical School in a Changing Policy Landscape: Consequences for Students and the Physician Pathway.

Annals of internal medicine·2026
Same author

Hepatitis B Vaccination at Birth: Safety, Effectiveness, and Public Health Benefit.

Pediatrics·2026
Same author

Cigarette smoking in PrEP recipients: a challenge and an opportunity.

The lancet. HIV·2026
Same author

Navigating Conflicting Vaccination Recommendations: Guidance for Clinicians.

JAMA·2026
Same author

Public Health Alerts - A New Section in <i>NEJM Evidence</i>, in Partnership with CIDRAP.

NEJM evidence·2025
Same author

From Crisis to Action - Policy Pathways to Reverse the Rise in Congenital Syphilis.

The New England journal of medicine·2025

Related Experiment Video

Updated: Mar 26, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.4K

Modeling and Cost-Effectiveness in HIV Prevention.

Margo M Jacobsen1, Rochelle P Walensky2,3,4

  • 1Medical Practice Evaluation Center (RPW, MMJ), Divisions of Infectious Diseases and General Internal Medicine (RPW), Massachusetts General Hospital, 50 Staniford Street, 9th Floor, Boston, MA, 02114, USA.

Current HIV/AIDS Reports
|February 3, 2016
PubMed
Summary

Cost-effectiveness analyses show most HIV prevention strategies are valuable, but affordability varies. Continued research is needed for budget-impact and combination approaches to manage the HIV epidemic effectively.

Keywords:
Cost-effectivenessHIVModelingPreventionReviewScience of prevention

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.5K
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

9.3K

Related Experiment Videos

Last Updated: Mar 26, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.4K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.5K
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

9.3K

Area of Science:

  • Public Health
  • Health Economics
  • Epidemiology

Background:

  • Global HIV funding is stagnating while the number of individuals living with HIV increases.
  • Antiretroviral therapy has improved longevity but strains healthcare budgets.
  • High HIV incidence in specific regions necessitates effective prevention strategies.

Purpose of the Study:

  • To review modeling and cost-effectiveness methodologies for HIV interventions.
  • To analyze the cost-effectiveness of various HIV prevention strategies.
  • To inform policy decisions regarding HIV epidemic management.

Main Methods:

  • Review of published cost-effectiveness analyses (CEAs).
  • Examination of modeling concepts and cost-effectiveness methodology.
  • Categorization of prevention strategies including condoms, circumcision, behavioral interventions, PMTCT, HIV testing, PrEP, and TasP.

Main Results:

  • Most reviewed HIV prevention strategies demonstrate cost-effectiveness.
  • The affordability of all interventions varies significantly.
  • High incidence populations require targeted, cost-effective prevention.

Conclusions:

  • Cost-effectiveness analysis is crucial for optimizing HIV intervention investments.
  • Affordability and budgetary impact are key considerations for policy.
  • Further research on combination strategies and willingness-to-pay is recommended.